Alteration in the level of pro-inflammatory cytokine (especially the IL-17A, IL-23 and IFN-γ) in T1D patients imply its significance as a potential pathogenesis marker, thereby extending the threat of developing diabetes related complications later in life. The gene discussed is IL17A; the disease is diabetes mellitus.